Radiofrequency Ablation in Cancer

Radiofrequency ablation, or RFA, is a local treatment that destroys tumour tissue by generating heat through an inserted probe. It is used in selected cancers and selected lesions, often when the goal is local control in a relatively limited area. It is not a universal substitute for surgery, chemotherapy, or radiotherapy, but in the right setting it can be an important part of treatment. ^[1][2][3]

How does radiofrequency ablation work?

RFA delivers thermal energy through a needle-like applicator placed into the target lesion under imaging guidance. The heat causes coagulative necrosis in the treated tissue. The technique is most useful when the tumour is of a size and location that allows effective destruction while limiting injury to nearby critical structures. That means the biology of the tumour matters, but so does anatomy. ^[1][2][4]

Because RFA treats a specific lesion rather than the entire body, it is considered a local therapy. This local nature is both its strength and its limit. It may help control a particular tumour focus, but it does not treat widespread microscopic disease elsewhere in the body. For that reason, it is often discussed as part of a broader oncologic plan rather than as a stand-alone answer. ^[1][2][5]

In whom might it be considered?

RFA may be considered for selected liver, kidney, lung, bone, or other lesions depending on tumour type, lesion number, size, location, and overall disease burden. It may be useful in people who are not ideal surgical candidates, in those with limited metastatic disease, or when local symptom control is needed. Eligibility depends on both technical feasibility and oncologic logic. A technically reachable lesion is not automatically the right lesion to ablate if the overall disease biology points to a different strategy. ^[1][2][3]

How is preparation performed before the procedure?

Before treatment, clinicians typically review imaging, coagulation status, organ function, and the relationship of the lesion to blood vessels, bile ducts, bowel, nerves, or other critical structures. The route of access and anaesthesia plan depend on the organ treated and the expected complexity. In interventional oncology, careful case selection is as important as the procedure itself. ^[1][2][4]

What are the advantages and limits?

Potential advantages include a less invasive approach than major surgery, the possibility of shorter recovery, and the option to repeat treatment in some settings. Limits include incomplete ablation, local recurrence, heat-sink effects near major vessels, inability to treat lesions close to vulnerable structures, and the fact that some tumours are simply better managed by surgery or systemic therapy. The most responsible way to present RFA is not as “easy cancer treatment,” but as a focused local tool with clearly defined indications. ^[1][2][5]

Risks and possible complications

Risks vary by organ and access route but may include bleeding, infection, pain, thermal injury to adjacent structures, pneumothorax in lung procedures, bile duct injury in liver procedures, or post-ablation syndrome with fever and malaise. Serious complications are not common in selected cases, but the risk profile must still be discussed honestly. ^[1][2][4]

What matters in follow-up?

Follow-up imaging is essential because the treated lesion must be assessed for complete response or residual viable tumour. One of the most important misunderstandings is assuming that symptom improvement alone proves the tumour has been eradicated. Imaging over time is what confirms technical and oncologic success. ^[1][2][5]

In which situations may RFA not be suitable?

RFA may be less suitable when tumours are too large, too numerous, unfavourably located, close to major vessels or sensitive structures, or when disease is widespread and systemic therapy is clearly the priority. The goal is not to force a local procedure into a situation where it adds little benefit. ^[1][2][3]

How does it fit alongside surgery and systemic treatment?

In some patients it is an alternative to surgery for selected lesions; in others it complements surgery, chemotherapy, targeted therapy, or immunotherapy. This is why multidisciplinary review is so important. The right question is not “Is RFA better?” but “What role does RFA play in this patient’s overall treatment strategy?” ^[1][2][5]

Does it have a role in pain and symptom control?

Yes, in selected situations RFA may help palliate pain or control a symptomatic lesion. The benefit depends on tumour type, location, and whether local control is likely to reduce the symptom burden meaningfully. ^[1][2]